Trial Profile
A non-interventional, comparative study of NivestimTM with reference filgrastim and pegfilgrastim in febrile neutropenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Oct 2016
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary) ; Pegfilgrastim
- Indications Febrile neutropenia
- Focus Therapeutic Use
- 12 Oct 2016 New trial record